Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : American Bio Medica (ABMC) drug test solution -taking off! -- Ignore unavailable to you. Want to Upgrade?

To: John Anderfuren who wrote (559)	9/24/1999 10:09:00 AM
From: Skywatcher	Respond to of 629

American Bio Medica Announces Overwhelming Approval At Annual Shareholders' Meeting KINDERHOOK, NY--(BUSINESS WIRE)--Sept. 24, 1999--American Bio Medica Corp. (NASDAQ: ABMC - news) today announced that its shareholders ratified all three issues brought to a vote at the Company's annual meeting held earlier this week at new company headquarters in Kinderhook, NY. The Company said that shareholders overwhelmingly approved all three issues at Wednesday's meeting. The issues brought for a shareholder vote were: 1. The re-appointment of American Bio Medica's directors 2. The adoption of the Company's Fiscal 2000 Non-qualified Stock Option Plan 3. The agreement to issue ABMC common shares in connection with the conversion and exercise of outstanding preferred stock and warrants issued in a private financing transaction ABMC representatives commented that they were very pleased with the results of the shareholder meeting as well as the discussion that followed the voting process. The Company noted that it addressed questions regarding top and bottom line results, stating that sales are expected to continue to rapidly increase and that management hopes to continue moving in a straight-line fashion towards profitability. American Bio Medica also said that shareholders were pleased the Company won the Friedenberg trial and were also happy about the resulting effect anticipated for shareholder value. American Bio Medica Corporation develops, manufactures, and markets inexpensive, accurate, on-site drugs of abuse diagnostic kits and support services worldwide. The Company's global distributors target the workplace, clinical, rehabilitation, physicians, corrections, and educational markets. ABMC's Rapid Drug Screen(TM) is proven to correlate 100% with the standard laboratory screening test. chris

To: John Anderfuren who wrote (559)	10/15/1999 10:38:00 AM
From: Skywatcher	Read Replies (1) \| Respond to of 629

American Bio Medica Files Second Patent Infringement and Trademark Dilution Lawsuit KINDERHOOK, N.Y.--(BUSINESS WIRE)--October 15, 1999--American Bio Medica Corp. (NASDAQ: ABMC - news) today announced that it filed a lawsuit in the United States District Court for the Southern District of Alabama against Larry Hartselle (and his company Instant Drug Detection), Gulf Supply Co., Inc. of Mobile, Alabama and Drug Detection Devices, Ltd. of Atlanta, Georgia. The suit alleges infringement of a U.S. design patent owned by American Bio Medica, trademark dilution of the Company's Rapid Drug Screen trademark and unfair competition. The Company claims that Instant Drug Detection is marketing a drug screening test that is a copy of American Bio Medica's Rapid Drug Screen(TM) on-site drug test, resulting in confusion in the marketplace. ABMC also claims that another copy of the Rapid Drug Screen is manufactured by Drug Detection Devices and distributed by Gulf Supply Co., thus resulting in further confusion in the marketplace. The Company has sought injunctive relief to prevent consumers' confusion, mistake or deception as a result of the defendants' alleged use of the Company's design, trademarks or service marks, as well as to prevent dilution of the Company's trademarks and service marks. The Company also seeks monetary damages. ''American Bio Medica continues to vigilantly defend its proprietary products and rights in the marketplace with lawsuits against parties that we learn are manufacturing and marketing knock off products of our patented drug tests,'' stated American Bio Medica CEO and Chairman Stan Cipkowski. ''We will continue our efforts to block all companies that infringe upon our patent and trademark rights and in the process harm the consuming public by letting people think that they are buying the Rapid Drug Screen instead of an unauthorized copy.'' It's UP on this BIG DOWN day! can't complain chris